Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Ward, Paul V. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S332000
Reexamination Certificate
active
08003655
ABSTRACT:
The invention relates to substituted sulphoximines according to the general formula (I):in which A, E, G, X, R1, R2, R3, R4, R5, R6, R7, R8, m, p, q, are given in the claims, and salts thereof, to pharmaceutical compositions comprising said substituted sulphoximines, to methods of preparing said substituted sulphoximines as well as the use thereof for manufacturing a pharmaceutical composition for the treatment of diseases of dysregulated vascular growth or of diseases which are accompanied with dysregulated vascular growth, wherein the compounds effectively interfere with Tie2 signalling.
REFERENCES:
patent: 2004/0102630 (2004-05-01), Brumby et al.
patent: WO 02/096888 (2002-12-01), None
patent: WO 03/066601 (2003-08-01), None
patent: WO 2005/037800 (2005-04-01), None
Pinedo et al., “Translational Research . . .”, The Oncologist 2000,, 5 (suppl1): 1-2 (www.The Oncologist .com).
McMahon, Gerald, “VEGF Receptor Signaling in Tumor Angiogenesis”, The Oncologist 2000; 5(suppl 1): 3-10 (www.The Oncologist.com).
Vippagunta et al., “Crystalline Solids”, Adv. Drug Del. Rev., 48 (2001) 3-26.
Boemer Ulf
Briem Hans
Hartung Ingo
Kettschau Georg
Krueger Martin
Bayer Schering Pharma AG
Millen White Zelano & Branigan P.C.
Ward Paul V.
LandOfFree
Substituted sulphoximines as TIE2 inhibitors and salts... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted sulphoximines as TIE2 inhibitors and salts..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted sulphoximines as TIE2 inhibitors and salts... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2693463